JXSL2000037 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products | Import Drug Application | 2020-04-15 | Daiichi Sankyo, Inc. | Daiichi Sankyo Co Ltd | In Review | 2020-04-14 | view |
JXSL2100002 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Import Drug Application | 2021-01-07 | Daiichi Sankyo, Inc. | Daiichi Sankyo Co Ltd | In Review | 2021-01-06 | view |
JXHB2100034 | AC220片 | quizartinib hydrochloride | Tablet | Chemical Drugs(1) | Supplementary Application | 2021-04-03 | Daiichi Sankyo, Inc. | Daiichi Sankyo Co Ltd | In Review | 2021-04-02 | view |
JXSL2000237 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Import Drug Application | 2021-01-01 | Daiichi Sankyo, Inc. | Daiichi Sankyo Co Ltd | In Review | 2021-01-01 | view |
JXHB2100035 | AC220片 | quizartinib hydrochloride | Tablet | Chemical Drugs(1) | Supplementary Application | 2021-04-03 | Daiichi Sankyo, Inc. | Daiichi Sankyo Co Ltd | In Review | 2021-04-02 | view |
JXSL2000178 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Import Drug Application | 2020-10-14 | Daiichi Sankyo, Inc. | Daiichi Sankyo Co Ltd | In Review | 2020-10-12 | view |
JXSL2100011 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Import Drug Application | 2021-01-25 | Daiichi Sankyo, Inc. | Daiichi Sankyo Co Ltd | In Review | 2021-01-25 | view |
JXSL2000147 | DS-8201a | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Import Drug Application | 2020-09-01 | Daiichi Sankyo, Inc. | Daiichi Sankyo Co Ltd | In Review | 2020-08-31 | view |